Dr. Oleg Varlamov, M.D., Ph.D., is an Associate Professor in the Division of Metabolic Health & Disease at the Oregon National Primate Research Center. Dr. Varlamov holds a degree in medical biochemistry from Pirogov Russian National Research Medical University and a doctorate in molecular pharmacology from the Albert Einstein College of Medicine. He completed his postdoctoral training at the Memorial Sloan Kettering Cancer Center in the laboratory of James Rothman, Ph.D.

Since 2009, Dr. Varlamov has been a faculty member at the ONPRC. His current research focuses on how maternal HIV and the antiretroviral therapy (ART) used to treat it, including long-acting ART, shape infant growth, hematopoiesis and immune development.

Dr. Varlamov’s earlier and continuing work centers on adipose tissue function in healthy and diseased states. A significant focus of this work is the consequences of maternal obesity for fetal development and hematopoiesis. His contributions also include unraveling the role of sex hormones in adipose tissue function and investigating how dietary factors affect physiological aspects of conditions such as obesity.